Search

everythinglearnresearchcommunity

for

Search:↓

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Microemulsions can improve skin delivery of finasteride.

Finasteride for hair loss in young men may significantly increase the risk of sexual dysfunction.

Two microRNAs affect hair follicle development in sheep by targeting specific genes.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

A mother and daughter had severe skin, hair, and eye issues linked to IFAP.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Treating underlying conditions and using antifungals effectively resolve Pityrosporum folliculitis in immunocompromised people.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Older age, family history, and low iron levels increase the risk of female hair loss.

AMF inoculation boosts tea plant growth and nutrient absorption.

Fentanyl accumulates differently in hair from internal use compared to external exposure.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Monilethrix, a genetic hair disorder causing fragile hair, affects three generations in a family.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Botox injections may be a safe and effective way to treat severe, itchy skin disease when other treatments fail.

PPCM microspheres allow controlled finasteride release over 24 hours.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.

A 6-year-old girl was diagnosed with a rare hair disorder and started treatment with topical minoxidil.